The Ratio of CD8 to Treg Tumor Infiltrating Lymphocytes Is Associated with Neoadjuvant Cisplatin Based Chemotherapy Response in Patients with Muscle Invasive Urothelial Carcinomas of the Bladder

被引：0
作者：
Baras, Alexander
Drake, Charles
Liu, Jen-Jane
Gandhi, Nilay
Kates, Max
Hoque, Mohamed
Meeker, Alan
Hahn, Noah M.
Schoenberg, Mark
Taube, Janis
Bivalacqua, Trinity J.
Netto, George J.
机构：
[1] Johns Hopkins, Baltimore, MD USA
[2] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
856
引用
收藏
页码：216A / 216A
页数：1
相关论文
共 50 条
[41]   Pathologic response rates between gemcitabine-cisplatin (GC) and methotrexate, vinblastine, doxorubicin hydrochloride, and cisplatin (MVAC) neoadjuvant chemotherapy in muscle-invasive urothelial cell carcinoma of the bladder [J].
Wright, Jonathan Lawrence ;
Lee, Franklin ;
Harris, William Proctor ;
Cheng, Heather H. ;
Zhao, Song ;
Champion, Thomas ;
Gore, John L. ;
Dean, James ;
Porter, Michael P. ;
Yu, Evan Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
[42]   Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies [J].
Cho, Sung Wook ;
Lim, Sung Hee ;
Kwon, Ghee Young ;
Kim, Chan Kyo ;
Park, Won ;
Pyo, Hongryull ;
Chung, Jae Hoon ;
Song, Wan ;
Sung, Hyun Hwan ;
Jeong, Byong Chang ;
Park, Se Hoon .
CANCER RESEARCH AND TREATMENT, 2024, 56 (03) :893-897
[43]   Correlations between tumor-infiltrating lymphocytes, CD3, CD8 cells, and Immunoscore®, with pathological CR and time to progression in triple-negative breast cancer patients undergoing neoadjuvant chemotherapy [J].
Rapoport, Bernardo Leon ;
Galon, Jerome ;
Nayler, Simon ;
Fugon, Aurelie ;
Boquet, Isabelle ;
Martel, Marine ;
Mlecnik, B. ;
Benn, Carol Ann ;
Smit, Teresa ;
Heyman, Liezl ;
Moosa, Farhana ;
Anderson, Ronald .
CANCER RESEARCH, 2021, 81 (04)
[44]   Identification of molecular biomarkers of cisplatin-based chemosensitivity in patients undergoing neoadjuvant chemotherapy for muscle-invasive bladder cancer. [J].
Shah, Paras Hemant ;
Lee, Annette ;
Zhu, Xinhua ;
Bradley, Thomas Paul ;
Vira, Manish Arvind ;
Korsunsky, Ilya .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
[45]   The ratio of CD8+lymphocytes to tumor-infiltrating suppressive FOXP3+effector regulatory T cells is associated with treatment response in invasive breast cancer [J].
Goda, Noriko ;
Sasada, Shinsuke ;
Shigematsu, Hideo ;
Masumoto, Norio ;
Arihiro, Koji ;
Nishikawa, Hiroyoshi ;
Sakaguchi, Shimon ;
Okada, Morihito ;
Kadoya, Takayuki .
DISCOVER ONCOLOGY, 2022, 13 (01)
[46]   CD8, FoxP3 and CD45Ro Positive Tumor Infiltrating Lymphocytes in Endometrial Carcinomas: Is There a Difference between European American and African American Patients? [J].
Rashid, Tariq ;
Pierce, Jennifer Young ;
Garrett-Mayer, Elizabeth ;
Spruill, Laura S. .
MODERN PATHOLOGY, 2016, 29 :304A-304A
[47]   CD8, FoxP3 and CD45Ro Positive Tumor Infiltrating Lymphocytes in Endometrial Carcinomas: Is There a Difference between European American and African American Patients? [J].
Rashid, Tariq ;
Pierce, Jennifer Young ;
Garrett-Mayer, Elizabeth ;
Spruill, Laura S. .
LABORATORY INVESTIGATION, 2016, 96 :304A-304A
[48]   Neoadjuvant cisplatin-based chemotherapy followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of the bladder: Post hoc analysis of two prospective studies. [J].
Kim, Min Jung ;
Cho, Sung Wook ;
Lim, Sung Hee ;
Park, Se Hoon .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[49]   PD-L1 Expression Patterns in Muscle-Invasive Bladder Carcinoma and Their Association with Immunohistochemical Phenotypes and CD8+Tumor Infiltrating Lymphocytes [J].
Bai, Yanfeng ;
Teng, Xiaodong .
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) :858-859
[50]   PD-L1 Expression Patterns in Muscle-Invasive Bladder Carcinoma and Their Association with Immunohistochemical Phenotypes and CD8+Tumor Infiltrating Lymphocytes [J].
Bai, Yanfeng ;
Teng, Xiaodong .
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) :858-859
12345